Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Journal of the American Podiatric Medical Association|September 1, 1990
Subchondral bone cysts of the phalangesH Lemont, A VisalliBehavioural Brain Research|March 6, 2023
The contribution of the supplementary motor area to explicit and implicit timing: A high-definition transcranial Random Noise Stimulation (HD-tRNS) studyM Capizzi, A Visalli, M Wiener, et al.Antimicrobial Agents and Chemotherapy|January 7, 1998
Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactamsM A Visalli, M R Jacobs, P C AppelbaumAntimicrobial Agents and Chemotherapy|April 29, 1998
Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodologyM A Visalli, M R Jacobs, P C AppelbaumAntimicrobial Agents and Chemotherapy|September 26, 1997
Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycinM A Visalli, M R Jacobs, P C AppelbaumDiagnostic Microbiology and Infectious Disease|July 1, 1997
Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-killM A Visalli, M R Jacobs, P C AppelbaumOncogene|March 28, 2003
fau and its ubiquitin-like domain (FUBI) transforms human osteogenic sarcoma (HOS) cells to anchorage-independenceToby G Rossman, Melissa A Visalli, Elena V KomissarovaAntimicrobial Agents and Chemotherapy|February 1, 1996
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococciM A Visalli, M R Jacobs, P C AppelbaumThe Journal of Antimicrobial Chemotherapy|January 1, 1996
Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodologyM A Visalli, M R Jacobs, P C AppelbaumAntimicrobial Agents and Chemotherapy|August 4, 1998
Activities of three quinolones, alone and in combination with extended-spectrum cephalosporins or gentamicin, against Stenotrophomonas maltophiliaM A Visalli, M R Jacobs, P C AppelbaumPageof 4